- Home
- AGNCM vs INM Comparison
AGNCM vs INM Comparison
Compare AGNCM & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGNCM
- INM
- Stock Information
- Founded
- AGNCM N/A
- INM 1981
- Country
- AGNCM United States
- INM Canada
- Employees
- AGNCM 53
- INM N/A
- Industry
- AGNCM Real Estate Investment Trusts
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- AGNCM Real Estate
- INM Health Care
- Exchange
- AGNCM Nasdaq
- INM Nasdaq
- Market Cap
- AGNCM N/A
- INM 3.2M
- IPO Year
- AGNCM N/A
- INM N/A
- Fundamental
- Price
- AGNCM $24.85
- INM $3.32
- Analyst Decision
- AGNCM
- INM
- Analyst Count
- AGNCM 0
- INM 0
- Target Price
- AGNCM N/A
- INM N/A
- AVG Volume (30 Days)
- AGNCM N/A
- INM 9.5M
- Earning Date
- AGNCM N/A
- INM 05-12-2025
- Dividend Yield
- AGNCM N/A
- INM N/A
- EPS Growth
- AGNCM N/A
- INM N/A
- EPS
- AGNCM N/A
- INM N/A
- Revenue
- AGNCM N/A
- INM $4,920,990.00
- Revenue This Year
- AGNCM N/A
- INM N/A
- Revenue Next Year
- AGNCM N/A
- INM N/A
- P/E Ratio
- AGNCM N/A
- INM N/A
- Revenue Growth
- AGNCM N/A
- INM N/A
- 52 Week Low
- AGNCM N/A
- INM $1.72
- 52 Week High
- AGNCM N/A
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- AGNCM 48.60
- INM 59.24
- Support Level
- AGNCM $25.13
- INM $2.26
- Resistance Level
- AGNCM $25.36
- INM $5.50
- Average True Range (ATR)
- AGNCM 0.17
- INM 0.40
- MACD
- AGNCM 0.02
- INM 0.11
- Stochastic Oscillator
- AGNCM 30.14
- INM 37.04
About AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock
AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.